Idenix Pharmaceuticals to Present at Four Upcoming Investor Conferences
CAMBRIDGE, Mass., Sept. 20 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the JMP Securities Healthcare Conference on Monday, September 27, 2010 at 10:30 a.m. ET at the Palace Hotel, New York City; the William Blair & Co. 2nd Annual Biotechnology Summit on Monday, October 4, 2010 at 4:45 p.m. at the InterContinental New York Barclay, New York City; Citi's 5th Annual Biotech Day on Tuesday, October 5, 2010 at 10:00 a.m. ET at the Westin Waterfront Hotel, Boston and the 9th Annual BIO Investor Forum on Tuesday, October 5, 2010 at 2:30 p.m. PT at the Palace Hotel, San Francisco.
The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com.
Idenix Pharmaceuticals Contact: |
|
Jonae Barnes (617) 224-4485 (investors) |
|
Kelly Barry (617) 995-9033 (media) |
|
SOURCE Idenix Pharmaceuticals, Inc.
Share this article